Lincoln Pharmaceuticals Limited (BOM:531633)

Market Cap	11.04B
Revenue (ttm)	5.98B
Net Income (ttm)	893.68M
Shares Out	20.03M
EPS (ttm)	44.61
PE Ratio	12.35
Forward PE	n/a
Dividend	1.80 (0.32%)
Ex-Dividend Date	Sep 13, 2024

Volume	2,760
Average Volume	4,329
Open	573.20
Previous Close	567.65
Day's Range	565.65 - 578.25
52-Week Range	498.00 - 975.00
Beta	0.34
RSI	42.68
Earnings Date	May 20, 2025

About Lincoln Pharmaceuticals

Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India. The company offers products in the areas of anticold, antibiotic, otolaryngology, pain management, gastro, anti-malarial, anti-fungal, corticosteroids and cosmo-derma, anti-diabetic, anti-hypertensive, gynecology, cardio and CNS, respiratory system, and dyslipidemic; and branded generics. It also exports its products to approximately 60 countries, including Europe, Canada, Latin and North America, Africa, the Asia Pacific, and South East As...

• Industry: Pharmaceutical Preparations
• Founded: 1979
• Employees: 1,687
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 531633

Financial Performance

In 2023, Lincoln Pharmaceuticals's revenue was 5.81 billion, an increase of 13.76% compared to the previous year's 5.10 billion. Earnings were 933.05 million, an increase of 27.99%.